ABIOMED Stock Price

0.42 (0.12%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
  Price Change Change Percent Stock Price Last Traded
0.42 0.12% 348.32 16:01:00
Open Price Low Price High Price Close Price Prev Close
348.00 345.34 352.70 348.065 347.90
Bid Price Ask Price Spread News
330.00 355.00 25.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,843 396,832 $ 349.57 $ 138,720,292 326,934 119.0101 - 353.49
Last Trade Time Type Quantity Stock Price Currency
16:10:15 priorref 273 $ 348.32 USD

ABIOMED Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.74B 45.19M 39.40M $ 840.88M $ 199.46M 4.42 76.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »


Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ABMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week332.63353.49325.985345.71334,09515.694.72%
1 Month307.34353.49306.16327.65322,08540.9813.33%
3 Months253.42353.49250.725294.34281,42694.9037.45%
6 Months293.00353.49242.73289.04294,68655.3218.88%
1 Year179.11353.49119.0101218.81458,491169.2194.47%
3 Years234.00459.75119.0101271.54594,599114.3248.85%
5 Years86.66459.7567.805224.76520,508261.66301.94%

ABIOMED Description

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.